Asset-swap deal sealed
By Ding Yining |
January 4, 2017, Wednesday
|
Print Edition
Print Edition
GERMANY’S Boehringer Ingelheim said it has officially completed the merger of its animal health care business with France-based Sanofi’s Merial as global pharmaceutical giants focus on core businesses while divesting loss-making units.
The two firms said in June last year they agree to an asset-swap deal where Sanofi would sell Merial, valued at 11.4 billion euros (US$11.9 billion), to Boehringer Ingelheim, whilst it would buy Boehringer’s consumer health care division, valued at 6.7 billion euros, and 4.7 billion euros in cash.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
